IGF1 and Hepatic fibrosis: Additionally, HCV infection negatively regulates the expression of glucose transporter-type 4 that is responsible for glucose uptake; therapy producing a state of insulin resistance [123], which leads to acceleration of liver fibrosis [124], and hepatocellular dysfunction that is usually followed by IGF-1 deficiency.